publication of a number of risk scoring systems like the San Francisco Syncope Rule, and the Risk Stratification of Syncope in the Emergency Department (ROSE) score to identify patients at risk for adverse outcomes, and identify need for further testing or hospitalization, their performance and acceptance has been suboptimal. [15] [16] [17] In the current era of high value care, an assessment of trends in the use of echocardiography can guide strategies targeting unnecessary testing and wasteful expenditure. In this study, we assessed the trends in use of echocardiography for patients admitted with syncope and its relation to hospital costs, length of stay, and in-hospital mortality using the National Inpatient Sample (NIS) database.
| ME THODS

| Data source
In this study, we used the National (Nationwide) Inpatient Sample (NIS) database, which is part of the Healthcare Cost and Utilization
Project (HCUP) family of databases sponsored by the Agency for
Healthcare Research and Quality (AHRQ) and is the largest publicly available fully de-identified all-payer inpatient healthcare database in the United States. 18 The NIS approximates a 20% stratified sample of all discharges from community hospitals in the United States, and when weighted, allows calculation of national estimates based on more than 35 million yearly hospitalizations.
| Study population
We queried the NIS database from 2001 to 2014 to identify hospitalizations with a primary diagnosis of syncope using the ICD-9-CM code:
780.2. This covers the diagnosis of syncope and collapse and can include vasovagal, micturition, tussive syncope, syncope due to orthostatic hypotension, and near fainting events. It excludes syncope due to carotid sinus hypersensitivity, heat, or mental illness. Echocardiography was identified using ICD-9-CM procedure code 88. as well as secondary cardiac diagnoses that were valve-, rhythm-, or structure-specific, and secondary diagnoses of aortic dissection or pulmonary embolism. See Table S1 for ICD-9-CM codes used to identify secondary diagnoses. We also extracted hospital characteristics that included location and teaching status (rural, urban nonteaching, urban teaching), region (northeast, midwest, south, west), and bed size (small, medium, large). 20, 21 We excluded hospitalizations in which the patient was younger than 18 years, transferred from another hospital, or patients who died within 1 day of admission. We also excluded hospitalizations with non-positive NIS weights and those missing any patient-or hospital-level data.
| Outcomes
Our outcomes included estimated rates of admission for syncope, rates of echocardiography utilization, and in-hospital mortality as well as length of stay, hospital cost (inflation-adjusted to 2014 US dollars) 22 and discharge disposition. Syncope rates are presented as hospitalizations per 1000 US population, calculated by multiplying by 1000 the quotient of the weighted frequency of syncope hospitalizations within a given year and mid-year US adult population estimates provided by the US Census Bureau for that year. 23 
| Statistical analysis
All patient and hospital characteristics were stratified by echocardiography. Continuous variables are presented as mean ± standard error and compared using linear regression to allow for NIS weighting, whereas categorical variables are presented as frequency and percent and compared using the Rao-Scott chi-square test using the estimated proportions as the design correction. All linear trend analyses were conducted using Spearman's rank correlation on yearly estimates (aka, Daniels test for trend). When appropriate,
Wilson confidence intervals are provided for categorical outcomes, whereas confidence intervals for length of stay and hospital cost were obtained from log-normal regression models. A logistic regression model was also estimated to assess if echocardiography was an independent predictor of in-hospital mortality. Finally, length of stay and total hospital cost were evaluated using log-normal regression models given both outcomes are bounded at zero and had heteroscedastic residuals. All analyses accounted for the NIS sampling design using updated hospital trend weights. SAS v. 9.4 was used for statistical analysis and P < 0.05 indicated statistical significance. This study was considered exempt research by the Creighton University Institutional Review Board. Tables 1 and 2 provide demographic and clinical characteristics, respectively, for syncope hospitalizations stratified by use of echocardiography. The overall rate of echocardiography was estimated to be 5.8% (95% CI: 5.1%-6.6%). Higher rates of echocardiography were observed in non-white patients (black: 8.4%, Hispanic: 7.3%, other: 10.6%), Medicaid recipients (8.6%), the uninsured (7.3%), those who lived in zip codes with the highest income quartile (7.1%) or the northeast (10.3%), and those seen in urban teaching hospitals (8.7%). A lower incidence of echocardiography was observed in rural or urban non teaching hospitals (2.9% and 3.9%, respectively) as well as in hospitals in the midwest or south (3.4% and 3.7%, respectively). Clinically, higher rates of echocardiography were noted in patients who had a valve-or structure-specific cardiac disease (8.9% and 14.2%, respectively).
| RE SULTS
| Trend analyses
| Demographic and clinical characteristics
| Predictors of in-hospital mortality
For hospitalizations without echocardiography, the unadjusted in-hospital mortality was estimated to be 0.22% (95% CI: 0.21- 
| Length of stay, hospital cost, and discharge disposition
On average, unadjusted length of stay for syncope hospitalizations that included echocardiography was 16.7% longer relative to hospitalizations that did not have an echocardiogram (95% CI: short-term facilities (1.5% vs 1.9%, P < 0.001) and skilled facilities (11.4% vs 12.5%, P = 0.001), and higher rates of discharge to home health (10.3% vs 9.0%, P < 0.001). 
TA B L E 2
| D ISCUSS I ON
The major findings of our study are (a) The estimated rates of ad- the ER. [24] [25] [26] Over the last few years, there has been a significant increase in the adoption of ER observation. 27, 28 It is also possible that this has resulted in low-risk patients being discharged from observation units and lower admission rates for syncope. Alternatively, this could be related to the increased emphasis on improving costs by healthcare systems or changes in rules of reimbursement like the implementation of the affordable care act. However, the latter is unlikely to be the primary cause as the decreasing trend was noted at least 1 year before its implementation. 29 Our study extends the findings of a previous study by Alsheklee et al using the NIS database from 2000 to 2005 and the more recent study by Anand et al. 3, 29 In addition to extending prior observations on mortality and admission rates through 2014, our study explored the trends in the use of echocardiography which is a frequently utilized diagnostic test in this population.
The overall in-hospital mortality rate is lower in our study com- where in-hospital mortality is reported to be around 0.2% and 10-day mortality around 0.7%. 30, 31 We found that increased age and male gender were associated with a higher in-hospital mortality which also agrees with findings from analyses of other administrative databases, as well as multiple observational studies. 3, 32, 33 Additionally, in our analysis, we found that a lower income quartile was associated with higher mortality. Potential reasons for this association could be more underlying structural heart disease, more advanced stage of disease before initial presentation, or the greater likelihood of presenting after recurrent syncope rather than the initial one in this particular subgroup of patients.
The rate of use of echocardiogram in our study population was relatively low despite the slight increasing trend over the study period.
Furthermore, despite the slight increase in percent use, the absolute number of patients undergoing echocardiography has decreased due to the significant reductions in hospitalization between 2009 and 2014. Prior research from the late nineties has suggested that routine echocardiogram use in unselected patients with syncope was common and was ordered in two-thirds of patients presenting with syncope. 34 However, subsequent investigations have demonstrated that echocardiographic abnormalities that impact treatment decisions are uncommon in unselected patients with syncope, particularly in those with a benign cardiac examination, normal ECG, and without preexisting cardiac disease. 6, 9, 35 The current ACC/AHA/HRS guidelines recommend against the routine use of cardiac imaging in the evaluation of patients with syncope unless cardiac etiology is suspected on the basis of an initial evaluation, including history, physical examination, or ECG. 12, 24 In our analysis, we found that echocardiogram use was associated with prior cardiac disease and higher comorbidity index suggesting that use of echocardiography may be consistent with in previous studies. 6, 39 While the reasons for its increased utilization in our study need further exploration, it is most likely a result of increased comorbidities and cannot be attributed to inappropriate use.
Alternatively, this could be artefactual due to better data collection/ capture over the more recent years. The fact that echocardiography use was associated with increased adjusted length of stay and cost also suggests that unmeasured bias due to inherently higher risk patients being admitted is the cause of increased percentage of patients getting echocardiography. These costs are unlikely to be direct costs attributable to echocardiography.
| CON CLUS ION
The rates of admission for syncope are decreasing since 2009. While the percentage of admitted patients receiving echocardiography has increased, the absolute number of patients undergoing echocardiography has decreased due to the favorable trends in admission.
In-hospital mortality of patients admitted with a principal diagnosis of syncope remains low and is not associated with the use of echocardiography.
| Limitations
Syncope has many causes and often overlapping etiologies, and the diagnosis can be inconsistent due to variability in patient, observer and physician interpretation. Table S1 . ICD-9-CM codes used to identify secondary diagnosis and additional procedures. 
